Pilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.
Jennifer L. Donovan, PharmD
Advertisement
Articles by Jennifer L. Donovan, PharmD
Advertisement
Latest Updated Articles
- Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting
Published: July 17th 2010 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
3
Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program
4
Supporting Pharmacy Residents in Completing Research Projects at UC Davis: Jeremiah J. Duby, PharmD, BCPS, BCCCP
5
